Learn More
Bio X Cell Antibody, Human CTLA-4, Ipilimumab, IgG1, 1 MG
Supplier: Bio X Cell SIM0004R001MG
This non-therapeutic biosimilar antibody targets human CTLA-4 (cytotoxic T lymphocyte antigen-4), also known as CD152. Utilizing the identical variable regions as the therapeutic antibody Ipilimumab, it is suitable for research applications. CTLA-4 is a 33 kDa cell surface receptor found on activated T and B lymphocytes, negatively regulating cell-mediated immune responses. Ipilimumab blocks CTLA-4's inhibitory signal, enabling cytotoxic T cells.
- Clone: Ipilimumab
- Reactivities: Human
- Isotype: Human IgG1
- Conjugation: Unconjugated
- Immunogen: Human CTLA-4
- Formulation: PBS, pH 7.0 (no stabilizers or preservatives)
- Endotoxin level: ≤0.5EU/mg
- Purity: ≥95%
- Molecular weight: 150 kDa
- Storage: Store at 4°C, do not freeze
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.